All news

MDV3100 cuts risk of death in advanced prostate cancer

Added: Wednesday 29 February 2012

Anti-androgen agent MDV3100 has been shown to reduce the risk of death in men with advanced prostate cancer for whom chemotherapy has failed.

+  http://www.oncologystat.com/news/MDV3100_Cuts_Risk_of_Death_in_Advanced_Prostate_Cancer_US.html;jsessionid=476BA8807F4F71CDE0274F3818D82035


//